BioScience Health Innovations I
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $712.4K | $1.1M | $661.9K | $1.1M | $1.3M | $1.0M | $662.5K | $333.2K |
| Accounts Receivable | $396.9K | $78.3K | $399.3K | $63.2K | $390.0K | $93.4K | $100.3K | $31.9K |
| Inventory | $797.2K | $874.3K | $336.3K | $757.5K | $248.5K | $215.7K | $58.3K | $42.2K |
| Total Current Assets | $2.0M | $2.2M | $1.6M | $2.0M | $2.0M | $1.3M | $847.8K | $408.8K |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $109.8K | $82.9K | $82.9K | $72.1K | $72.1K | $56.0K | $26.0K | $7.0K |
| Total Assets | $2.1M | $2.3M | $1.7M | $2.1M | $2.1M | $1.4M | $873.8K | $415.8K |
| Liabilities | ||||||||
| Accounts Payable | $9.7K | $6.8K | $6.3K | $10.2K | $16.6K | $16.4K | $8.2K | $8.4K |
| Total Current Liabilities | — | — | — | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $301.2K | $645.7K | $229.9K | $356.1K | $337.6K | $132.9K | $38.5K | $45.5K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-114.7K | $71.1K | $301.0K | $534.6K | $543.4K | $85.7K | $-341.1K | $-351.0K |
| Total Stockholders' Equity | $1.8M | $1.7M | $1.5M | $1.7M | $1.7M | $1.3M | $835.2K | $370.3K |